RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Windham Venture Partners
W

Windham Venture Partners portfolio

Windham Venture Partners has 2 portfolio companies on record at Recent Funding. Its most recent investment on record is Personal Genome Diagnostics's $100M Series B+ round in February 2021, alongside Vensana Capital, Sands Capital Ventures, Rock Springs Capital and 6 others. By category, its portfolio leans toward Health and bio (2) and Data and analytics (1). It has co-invested with NEA, Innovatus Capital Partners and Rock Springs Capital, most often NEA (2 rounds).

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Capital in their rounds: $121M.
Latest deal: Personal Genome Diagnostics · Feb 1, 2021.

What Windham Venture Partners invests in

How Windham Venture Partners invests

StageDealsCapital in rounds
Series B+ 1 50%$100M
Series A 1 50%$21M
YearDealsCapital in rounds
2015 1 50%$21M
2021 1 50%$100M

Share is of the 2 rounds on Recent Funding that name Windham Venture Partners. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Windham Venture Partners portfolio companies

CompanyRound with Windham Venture PartnersTotal raisedLatest raise
PPersonal Genome Diagnostics
Health and bio
Series B+ · $100M$123.8MNov 24, 2025
Series B+
NNeuspera
Health and bio
backer$23MJul 15, 2024
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Windham Venture Partners, which is a subset of its real portfolio. API: /api/v1/investors/windham-venture-partners (get a free API key). More: the most active VC firms and new venture capital funds.